eHealthInsurance

eHealth, Inc. Announces Second Quarter 2021 Results

Retrieved on: 
Thursday, July 29, 2021

SANTA CLARA, Calif., July 29, 2021 /PRNewswire/ --eHealth, Inc.(Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2021.

Key Points: 
  • SANTA CLARA, Calif., July 29, 2021 /PRNewswire/ --eHealth, Inc.(Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the second quarter ended June 30, 2021.
  • A webcast and conference call will be held today, Thursday, July 29, 2021 at 5:00 p.m. Eastern / 2:00 p.m. Pacific Time to discuss these results.
  • The live webcast and supporting presentation slides will be available on the Investor Relations section of eHealth's website at http://ir.ehealthinsurance.com .
  • Since 1997, we have connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans.

Bright Health Group Announces Pricing of Initial Public Offering

Retrieved on: 
Thursday, June 24, 2021

Bright Health Group today announced the pricing of its initial public offering of 51,350,000 shares of its common stock at a price to the public of $18.00 per share.

Key Points: 
  • Bright Health Group today announced the pricing of its initial public offering of 51,350,000 shares of its common stock at a price to the public of $18.00 per share.
  • As part of the offering, Bright Health Group has granted the underwriters a 30-day option to purchase up to an additional 6,162,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
  • The gross proceeds to Bright Health Group from the offering will be approximately $924.3 million (or $1.035 billion if the underwriters exercise their option to purchase additional shares of common stock in full), before deducting the underwriting discount and estimated offering expenses.
  • Through Bright HealthCare we offer Medicare and Commercial health plan products to approximately 623,000 consumers in 14 states and 99 markets.

Cyteir Therapeutics Announces Closing of Initial Public Offering

Retrieved on: 
Tuesday, June 22, 2021

Cyteir Therapeutics, Inc. (Cyteir) (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced the closing of its initial public offering of 7,400,000 shares of its common stock at an initial public offering price of $18.00 per share.

Key Points: 
  • Cyteir Therapeutics, Inc. (Cyteir) (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced the closing of its initial public offering of 7,400,000 shares of its common stock at an initial public offering price of $18.00 per share.
  • In addition, Cyteir has granted the underwriters a 30-day option to purchase up to an additional 1,110,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.
  • The gross proceeds to Cyteir from the offering were $133.2 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
  • This press release contains forward-looking statements regarding Cyteirs plans for its proposed initial public offering.

Marqeta Announces Full Exercise and Closing of Underwriters' Option to Purchase Additional Shares

Retrieved on: 
Thursday, June 17, 2021

Marqeta, Inc. (NASDAQ: MQ) today announced that the underwriters of its initial public offering have exercised in full their option to purchase from Marqeta an additional 6,818,181 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions.

Key Points: 
  • Marqeta, Inc. (NASDAQ: MQ) today announced that the underwriters of its initial public offering have exercised in full their option to purchase from Marqeta an additional 6,818,181 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions.
  • The sale of these additional shares of Class A common stock closed earlier today, following the closing on June 11, 2021 of the sale of 45,454,546 shares of Marqetas Class A common stock.
  • As a result, Marqeta has received total gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, of approximately $1.41 billion.
  • Goldman Sachs & Co. LLC and J.P. Morgan acted as lead book-running managers for the offering.

eHealth Launches Inaugural Signature Research Report: Health Insurance Trends

Retrieved on: 
Wednesday, May 26, 2021

(NASDAQ: EHTH) released the inaugural edition of its bi-annual signature research series: Health Insurance Trends .

Key Points: 
  • (NASDAQ: EHTH) released the inaugural edition of its bi-annual signature research series: Health Insurance Trends .
  • Hundreds of millions of Americans have felt the impact of the COVID-19 pandemic, not only in their personal lives but also in how they interact with health care.
  • eHealth, Inc. (NASDAQ: EHTH) operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insurance enrollment solutions.
  • Since 1997, we have connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans.

eHealth, Inc. to Present at Jefferies Healthcare Conference

Retrieved on: 
Tuesday, May 18, 2021

b"SANTA CLARA, Calif., May 18, 2021 /PRNewswire/ -- eHealth, Inc.(NASDAQ: EHTH), a leading private online health insurance marketplace, today announced that its management will present at theJefferies Healthcare Conference onTuesday, June 1, 2021at 11:30 a.m. E.T.

Key Points: 
  • b"SANTA CLARA, Calif., May 18, 2021 /PRNewswire/ -- eHealth, Inc.(NASDAQ: EHTH), a leading private online health insurance marketplace, today announced that its management will present at theJefferies Healthcare Conference onTuesday, June 1, 2021at 11:30 a.m. E.T.
  • Interested investors can access the live audio webcast of eHealth's presentation at www.ehealthinsurance.com under Investor Relations.
  • Please visit the website at least 15 minutes early to register, download, and install any necessary software.
  • Since 1997, we have connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans.

eHealth, Inc. Announces First Quarter 2021 Results

Retrieved on: 
Thursday, April 29, 2021

b"SANTA CLARA, Calif., April 29, 2021 /PRNewswire/ --eHealth, Inc.(Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2021.

Key Points: 
  • b"SANTA CLARA, Calif., April 29, 2021 /PRNewswire/ --eHealth, Inc.(Nasdaq: EHTH), a leading private online health insurance marketplace, today announced its financial results for the first quarter ended March 31, 2021.
  • View the full press release in PDF .\nA Webcast and conference call will be held today, Thursday, April29, 2021 at 5:00 p.m. Eastern / 2:00 p.m. Pacific Time.The live Webcast and supporting presentation slides will be available on the Investor Relations section of eHealth's website at http://ir.ehealthinsurance.com .
  • Individuals interested in listening to the conference call may do so by dialing (877) 930-8066 for domestic callers and (253) 336-8042 for international callers.
  • Since 1997, we have connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans.

Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Wednesday, April 7, 2021

All of the shares to be sold in the offering are being sold by Crinetics.

Key Points: 
  • All of the shares to be sold in the offering are being sold by Crinetics.
  • The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $75.0 million.
  • The offering is expected to close on or about April 12, 2021, subject to the satisfaction of customary closing conditions.
  • Crinetics intends to use the net proceeds from the proposed offering to fund the development of paltusotine and its other research and development programs, and for working capital and general corporate purposes.

Medicare Supplement Buyers Can Save An Average of $840 Annually Through Comparison Shopping for the Lowest-Cost Option in Their Area, eHealth Analysis Finds

Retrieved on: 
Wednesday, March 31, 2021

eHealth calculated potential savings by comparing the lowest-cost and highest-cost Medicare Supplement plans within each plan type available through eHealth for 65-year-olds in 67 metropolitan areas.

Key Points: 
  • eHealth calculated potential savings by comparing the lowest-cost and highest-cost Medicare Supplement plans within each plan type available through eHealth for 65-year-olds in 67 metropolitan areas.
  • Medicare Supplement plans (also known as Medigap plans) are offered by private insurers and are designed to fill many of the coverage gaps in Original Medicare.
  • Plan G is widely seen as the optimal replacement for the formerly most popular Plan F, which is being phased out.
  • On average, Medicare beneficiaries shopping at eHealth had 6 Plan N options to choose from.

Stratasys Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares in Public Offering

Retrieved on: 
Thursday, March 18, 2021

Stratasys Ltd. (Nasdaq: SSYS) today announced that the underwriters of its previously announced public offering of ordinary shares have fully exercised their option to purchase an additional 1,034,482 shares at the public offering price of $29.00 per share, less underwriting discounts and commissions, resulting in additional gross proceeds of approximately $30 million.

Key Points: 
  • Stratasys Ltd. (Nasdaq: SSYS) today announced that the underwriters of its previously announced public offering of ordinary shares have fully exercised their option to purchase an additional 1,034,482 shares at the public offering price of $29.00 per share, less underwriting discounts and commissions, resulting in additional gross proceeds of approximately $30 million.
  • After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Stratasys in the public offering increased to 7,931,034 shares and gross proceeds increased to approximately $230 million, before deducting underwriting discounts and commissions and other offering expenses.
  • The closing of the underwriters option to purchase additional shares is expected to occur today, March 18, 2021, subject to customary closing conditions.
  • J.P. Morgan and Stifel acted as lead book-running managers for the offering.